Literature DB >> 8199117

Oculocutaneous manifestations in xeroderma pigmentosa.

J L Goyal1, V A Rao, R Srinivasan, K Agrawal.   

Abstract

Xeroderma pigmentosum (XP) is a rare genetic disease characterised by defective DNA repair leading to clinical and cellular hypersensitivity to ultraviolet radiation. The oculocutaneous features of 10 patients with XP were studied retrospectively. General features included parental consanguinity (40%), familiarity (60%), onset of symptoms in first 2 years (50%), malignant skin neoplasms (60%), and carcinoma of the tongue (20%). Among the ocular features, 50% of patients presented with photophobia. Lid freckles or atrophic skin lesions were seen in all patients. Lower lid tumours were seen in 30%, chronic conjunctival congestion in 40%, corneal opacification in 40%, squamous cell carcinoma of limbus in 20%, bilateral pterygium in 40%, and visual impairment in 50%. The clinical features (ocular and cutaneous) of the cases are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 8199117      PMCID: PMC504766          DOI: 10.1136/bjo.78.4.295

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Repair of DNA in xeroderma pigmentosum conjunctiva.

Authors:  D A Newsome; K H Kraemer; J H Robbins
Journal:  Arch Ophthalmol       Date:  1975-08

2.  Significance of repair of human DNA: evidence from studies of xeroderma pigmentosum.

Authors:  J H Robbins
Journal:  J Natl Cancer Inst       Date:  1978-09       Impact factor: 13.506

3.  Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration.

Authors:  J H Robbins
Journal:  JAMA       Date:  1988-07-15       Impact factor: 56.272

4.  Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair.

Authors:  J H Robbins; K H Kraemer; M A Lutzner; B W Festoff; H G Coon
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

5.  Defective repair replication of DNA in xeroderma pigmentosum.

Authors:  J E Cleaver
Journal:  Nature       Date:  1968-05-18       Impact factor: 49.962

6.  Xeroderma pigmentosum. Clinical and laboratory investigation of its basic defect.

Authors:  W B Reed; B Landing; G Sugarman; J E Cleaver; J Melnyk
Journal:  JAMA       Date:  1969-03-17       Impact factor: 56.272

Review 7.  Xeroderma pigmentosum.

Authors:  E G Jung
Journal:  Int J Dermatol       Date:  1986-12       Impact factor: 2.736

8.  Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.

Authors:  K H Kraemer; M M Lee; J Scotto
Journal:  Arch Dermatol       Date:  1987-02

9.  Malignant melanoma of the iris in xeroderma pigmentosum.

Authors:  M W Johnson; G L Skuta; M C Kincaid; C C Nelson; J R Wolter
Journal:  Arch Ophthalmol       Date:  1989-03

10.  Epibulbar squamous cell carcinomas in brothers with Xeroderma pigmentosa.

Authors:  R W Hertle; F Durso; J P Metzler; E W Varsa
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1991 Nov-Dec       Impact factor: 1.402

View more
  21 in total

Review 1.  Xeroderma pigmentosum with bilateral ocular surface squamous neoplasia and review of the literature.

Authors:  Charudutt Kalamkar; Nishant Radke; Amrita Mukherjee; Snehal Radke
Journal:  BMJ Case Rep       Date:  2016-05-10

Review 2.  Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.

Authors:  Hema L Ramkumar; Brian P Brooks; Xiaoguang Cao; Deborah Tamura; John J Digiovanna; Kenneth H Kraemer; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 6.048

3.  Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome.

Authors:  Noopur Gupta; Ritika Sachdev; Radhika Tandon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-12       Impact factor: 3.117

4.  Xeroderma pigmentosum: clinicopathological review of the multiple oculocutaneous malignancies and complications.

Authors:  Rajshekar Halkud; Ashok M Shenoy; Sudhir M Naik; Purshottam Chavan; K T Sidappa; Siddharth Biswas
Journal:  Indian J Surg Oncol       Date:  2014-04-09

5.  Type I keratoprosthesis for visual rehabilitation of patients with xeroderma pigmentosum.

Authors:  Shiji Ummar; Swapnil Bhalekar; Virender Sangwan
Journal:  BMJ Case Rep       Date:  2014-01-31

6.  Atypical Fibroxanthoma of the Conjunctiva in Xeroderma Pigmentosum.

Authors:  Nabeel Shalabi; Anat Galor; Sander R Dubovy; Jordan Thompson; J Antonio Bermudez-Magner; Carol L Karp
Journal:  Ocul Oncol Pathol       Date:  2015-04-15

7.  Clinicopathological Features of Ophthalmic Neoplasms Arising in the Setting of Xeroderma Pigmentosum.

Authors:  Maria J Suarez; Roxana Rivera-Michlig; Sander Dubovy; Fausto J Rodriguez
Journal:  Ocul Oncol Pathol       Date:  2015-11-12

8.  Cutaneous malignancies in xeroderma pigmentosum: earlier management improves survival.

Authors:  Sudhir M Naik; Ashok M Shenoy; A Nanjundappa; Rajshekar Halkud; Purshottam Chavan; K Sidappa; Sumit Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-01-05

9.  Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.

Authors:  Brian P Brooks; Amy H Thompson; Rachel J Bishop; Janine A Clayton; Chi-Chao Chan; Ekaterini T Tsilou; Wadih M Zein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Nicholas T Iliff; Porcia Bradford; John J Digiovanna; Kenneth H Kraemer
Journal:  Ophthalmology       Date:  2013-04-16       Impact factor: 12.079

10.  Orbital amelanotic melanoma in xeroderma pigmentosum: a rare association.

Authors:  Syed Ar Rizvi; Abadan K Amitava; Ghazala Mehdi; Rajeev Sharma; Mohammad S Alam
Journal:  Indian J Ophthalmol       Date:  2008 Sep-Oct       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.